BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

999 related articles for article (PubMed ID: 31484506)

  • 1. Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia.
    Zhang J; Healy HG; Venuthurupalli SK; Tan KS; Wang Z; Cameron A; Hoy WE
    BMC Nephrol; 2019 Sep; 20(1):348. PubMed ID: 31484506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension Control in Adults With CKD in China: Baseline Results From the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).
    Yan Z; Wang Y; Li S; Wang J; Zhang L; Tan H; Li S; Yang L; Pei H; Zhang L; Wang Y; Duan J; Jiao S; Zhao M; Fu S;
    Am J Hypertens; 2018 Mar; 31(4):486-494. PubMed ID: 29304216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
    Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
    Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal blood pressure target and measurement in patients with chronic kidney disease.
    Kim CS; Choi HS; Bae EH; Kim SW; Ma SK
    Korean J Intern Med; 2019 Nov; 34(6):1181-1187. PubMed ID: 31189302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure control and kidney damage in hypertension: Results of a three-center cross-sectional study in North Central Nigeria.
    Abene EE; Gimba ZM; Edah JO; Akinbuwa BA; Uchendu DG; Onyenuche C; Ojo OS; Tzamaloukas AH; Agaba EI
    Niger J Clin Pract; 2020 Nov; 23(11):1590-1597. PubMed ID: 33221787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney disease.
    Azushima K; Wakui H; Uneda K; Haku S; Kobayashi R; Ohki K; Kinguchi S; Haruhara K; Fujikawa T; Toya Y; Umemura S; Tamura K
    Clin Exp Hypertens; 2017; 39(7):665-671. PubMed ID: 28635327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory Blood Pressure Phenotypes in Adults Taking Antihypertensive Medication with and without CKD.
    Mwasongwe SE; Tanner RM; Poudel B; Pugliese DN; Young BA; Abdalla M; Musani SK; Gutiérrez OM; Correa A; Shimbo D; Muntner P
    Clin J Am Soc Nephrol; 2020 Apr; 15(4):501-510. PubMed ID: 32217635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood Pressure Control During Chronic Kidney Disease Progression.
    Lee S; Oh HJ; Lee EK; Lee O; Ha E; Kim SJ; Kang DH; Choi KB; Ryu DR
    Am J Hypertens; 2017 Jun; 30(6):610-616. PubMed ID: 28338771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease, Queensland: Profile of patients with chronic kidney disease from regional Queensland, Australia: A registry report.
    Venuthurupalli SK; Healy H; Fassett R; Cameron A; Wang Z; Hoy WE
    Nephrology (Carlton); 2019 Dec; 24(12):1257-1264. PubMed ID: 30663166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, awareness, treatment, and control of hypertension in the non-dialysis chronic kidney disease patients.
    Zheng Y; Cai GY; Chen XM; Fu P; Chen JH; Ding XQ; Yu XQ; Lin HL; Liu J; Xie RJ; Wang LN; Ni ZH; Liu FY; Yin AP; Xing CY; Wang L; Shi W; Liu JS; He YN; Ding GH; Li WG; Wu GL; Miao LN; Chen N; Su Z; Mei CL; Zhao JY; Gu Y; Bai YK; Luo HM; Lin S; Chen MH; Gong L; Yang YB; Yang XP; Li Y; Wan JX; Wang NS; Li HY; Xi CS; Hao L; Xu Y; Fang JA; Liu BC; Li RS; Wang R; Zhang JH; Wang JQ; Lou TQ; Shao FM; Mei F; Liu ZH; Yuan WJ; Sun SR; Zhang L; Zhou CH; Chen QK; Jia SL; Gong ZF; Guan GJ; Xia T; Zhong LB;
    Chin Med J (Engl); 2013 Jun; 126(12):2276-80. PubMed ID: 23786938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension in Chronic Kidney Disease.
    Hamrahian SM; Falkner B
    Adv Exp Med Biol; 2017; 956():307-325. PubMed ID: 27873228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
    BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care.
    Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW
    BMC Fam Pract; 2013 Jun; 14():88. PubMed ID: 23800117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of chronic kidney disease and blood pressure control status in elderly hypertensive patients.
    Hasegawa E; Tsuchihashi T; Ohta Y
    Intern Med; 2012; 51(12):1473-8. PubMed ID: 22728477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of renin-angiotensin-aldosterone system blockers on the progression of chronic kidney disease in hypertensive elderly patients without proteinuria: PROERCAN study. Rationale and design.
    García-Prieto AM; Verdalles Ú; de José AP; Verde E; Arroyo D; Aragoncillo I; Linares T; Barbieri D; Goicoechea M
    Hipertens Riesgo Vasc; 2020; 37(3):101-107. PubMed ID: 32156479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a Primary Care CKD Registry in a US Public Safety-Net Health Care Delivery System: A Pragmatic Randomized Trial.
    Tuot DS; McCulloch CE; Velasquez A; Schillinger D; Hsu CY; Handley M; Powe NR
    Am J Kidney Dis; 2018 Aug; 72(2):168-177. PubMed ID: 29699885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study.
    Vidal-Petiot E; Metzger M; Faucon AL; Boffa JJ; Haymann JP; Thervet E; Houillier P; Geri G; Stengel B; Vrtovsnik F; Flamant M;
    J Am Heart Assoc; 2018 Oct; 7(19):e010278. PubMed ID: 30371309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Chronic Kidney Disease Management in Canadian Primary Care.
    Bello AK; Ronksley PE; Tangri N; Kurzawa J; Osman MA; Singer A; Grill AK; Nitsch D; Queenan JA; Wick J; Lindeman C; Soos B; Tuot DS; Shojai S; Brimble KS; Mangin D; Drummond N
    JAMA Netw Open; 2019 Sep; 2(9):e1910704. PubMed ID: 31483474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease.
    Mojón A; Ayala DE; Piñeiro L; Otero A; Crespo JJ; Moyá A; Bóveda J; de Lis JP; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):145-58. PubMed ID: 23181690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease.
    Bakris G; Chen C; Campbell AK; Ashton V; Haskell L; Singhal M
    Am J Hypertens; 2024 May; 37(6):438-446. PubMed ID: 38436491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.